Executive Director, Global Pricing Strategy and Operations

Revolution Medicines

12d•$256,000 - $320,000•Onsite

About The Position

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding Revolutionaries in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Executive Director, Global Pricing will serve as the company’s first dedicated Global pricing leader, responsible for building the global pricing function, infrastructure, and strategy to support the commercial launch and long-term value optimization of the company’s innovative therapies. This leader will establish global pricing governance, partner to develop launch pricing strategies, and ensure pricing decisions align with clinical value, market access goals, and the company’s mission to deliver transformative medicines to patients. The Executive Director will work cross-functionally with Market Access, Commercial, HEOR, Finance, Regulatory, Clinical, and program teams to shape pricing considerations. The position will report to the VP, Global Value, Access and Pricing.

Requirements

Bachelor’s degree required; advanced degree in Finance, Pharmacy, Health Economics, Life Sciences, or Business preferred (e.g., PharmD, PhD, MBA).
Minimum 15+ years of progressive leadership in market access, pricing, and / or finance within the biopharma industry.
Demonstrated ability to build a new Pricing function to support a Global Market Access commercialization strategy.
Deep understanding of global payer systems and HTA processes.
Experience designing and implementing global pricing strategy, including value-based pricing, launch sequencing, and reference pricing mitigation.
Proven ability to work cross-functionally and influence executive leadership in a dynamic, resource-constrained, early-stage company.

Nice To Haves

Prior experience with pharmaceutical pricing strategy in U.S. and global markets. Strong understanding of global health systems, health policy, pricing regulations, reimbursement environments and familarity with key U.S. and Global price policy trends.
Familiarity with rare disease, or oncology product launches.
Strong executive presence, with the ability to clearly articulate complex pricing issues to both internal and external stakeholders.
Experience building or scaling global pricing function in a pre-commercial or newly commercial biotech company.

Responsibilities

Design and implement the company’s first global pricing framework, policies, SOPs, governance committees, and approval workflows.
Develop global pricing infrastructure including systems, tools, analytics platforms, dashboards, and documentation standards.
Define the operating model for pricing interactions and partnering with future regional teams.
Create foundational IRP, net-price management tools and processes.
Develop portfolio wide pricing principles, policies and advance best practices to optimize value recognition by stakeholders globally.
Establish a compliant global pricing governance model with clear decision-rights and escalation pathways.
Ensure adherence to global regulatory requirements, including national pricing rules, IRP risks, anti-trust considerations.
Implement controls to monitor price changes, discounting, contracting, and tender strategy.
Lead strategic initiatives related to product launches, price optimization and analytics.
Engage with Regions to incorporate payer, policy insights and global trends into enterprise pricing strategies.
Develop and maintain strong business relationships with key functions with a focus on Clinical, Commercial, Regulatory, and Finance.
Collaborate with regional pricing teams, IT and Finance to ensure data quality, system integrity and actionable insights.
Coordinate with regions to align on policy and legislation risks that could impact global pricing strategies and tactics.